顶刊论文（社媒热度）· Nat Med·· 12 hours agoPickScore57
Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women.
In brief
A prospective observational study in the UK followed 8,127 women initiating GLP-1 receptor agonist therapy (99.8% tirzepatide) through a digital program with mandatory biochemical monitoring, weekly video follow-up and clinician-guided dose titration.
Why it matters
Provides prospective real-world evidence in 8,127 women, where GLP-1 receptor agonist RCT coverage is limited.
Source: 顶刊论文（社媒热度）